First-in-Human Trial of Anti-AXL Antibody-Drug Conjugate in Advanced Lung Cancer
ESMO 2019: First-Line Osimertinib in Patients With EGFR-Mutated Advanced NSCLC
WCLC 2019: Comparison of Screening Methods for Those at Risk of Lung Cancer
WCLC 2019: Blood Biomarker–Based Lung Cancer Screening
Extended Follow-up From the National Lung Screening Trial
Insurance and Mortality in Lung and Other Cancers
Early Palliative Care and Survival in Patients With Advanced Lung Cancer
Oral Nelfinavir With Chemoradiotherapy for Locally Advanced Lung Cancer
Proceedings from the 15th Annual Winter Lung Cancer Conference
Advanced Non-Small Cell Lung Ccancer Patient Management Simulator
An Advanced Practitioner’s Guide to Cell Signaling Pathways in NSCLC
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care-Lung Cancer: Advanced Disease
Yale Cancer Center / Smilow Cancer Hospital
Memorial Sloan Kettering Cancer Center
University of Wisconsin Carbone Cancer Center
Huntsman Cancer Institute at the University of Utah
Nivolumab (NSCLC)
Dabrafenib + Trametinib
Afatinib
Pembrolizumab (NSCLC)
Lung Cancer Alliance
Free ME from Lung Cancer
The American Lung Association
Dusty Joy Foundation
